molecular testing and implications for adjuvant therapy in early stage nsclc
Published 2 years ago • 77 plays • Length 24:45Download video MP4
Download video MP3
Similar videos
-
5:28
adjuvant chemotherapy for early stage nsclc patients part 1
-
32:51
adjuvant therapy for early stage lung cancer – case based discussion for patient with stage 1b nsclc
-
42:02
molecular testing and implications for adjuvant therapy in early stage nsclc
-
28:19
molecular testing and implications for adjuvant therapy in early stage nsclc
-
7:02
adjuvant chemotherapy /- bevacizumab for early stage nsclc
-
10:20
role of adjuvant osimertinib in early stage nsclc
-
1:17
dr. christina baik on alectinib versus crizotinib in alk-positive lung cancer
-
4:23
alecensa: targeted therapy for alk-positive lung cancer
-
3:44
pembro plus chemo followed by resection and adjuvant pembro improves on soc for early nsclc
-
3:04
management of frontline alk nsclc: brigatinib vs. alectinib
-
1:06
comparing alectinib versus crizotinib in alk nsclc
-
2:00
updated data from phase 2 study of alectinib in alk–positive non–small–cell lung cancer
-
3:59
alectinib in alk-mutated nsclc
-
7:04
adjuvant chemotherapy for visceral pleural invasion in 3–4 centimeter non-small cell...(title cont.)
-
5:03
adaura results: adjuvant osimertinib for egfrm non-small cell lung cancer
-
1:41
adjuvant atezolizumab in nsclc
-
3:04
phase iii results for alectinib compared with crizotinib in alk metastatic nsclc
-
2:20
adjuvant osimertinib in resected egfrm nsclc: the os data from the adaura trial
-
0:52
dr. stinchcombe on the benefit of alectinib in alk nsclc